Bridgeway Capital Management’s Solid Biosciences SLDB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$169K	Hold	23,460	–	–	﹤0.01%	1063
2025 Q4	$132K	Sell	23,460 -15,000	-39%	-$81.3K	﹤0.01%	1090
2025 Q3	$237K	Sell	38,460 -60,071	-61%	-$351K	0.01%	981
2025 Q2	$480K	Buy	98,531 +15,000	+18%	+$53K	0.01%	784
2025 Q1	$309K	Sell	83,531 -19,100	-19%	-$81.8K	0.01%	835
2024 Q4	$411K	Buy	102,631 +51,574	+101%	+$283K	0.01%	856
2024 Q3	$356K	Hold	51,057	–	–	0.01%	942
2024 Q2	$289K	Hold	51,057	–	–	0.01%	973
2024 Q1	$680K	Hold	51,057	–	–	0.01%	837
2023 Q4	$313K	Buy	51,057 +15,000	+42%	+$48K	0.01%	1058
2023 Q3	$90.9K	Buy	36,057 +10,000	+38%	+$38.8K	﹤0.01%	1244
2023 Q2	$137K	Sell	26,057 -8,629	-25%	-$48.6K	﹤0.01%	1208
2023 Q1	$164K	Buy	34,686 +15,000	+76%	+$90.1K	﹤0.01%	1136
2022 Q4	$106K	Sell	19,686 -1	-0%	-$7	﹤0.01%	1206
2022 Q3	$138K	Hold	19,687	–	–	﹤0.01%	1216
2022 Q2	$182K	Sell	19,687 -6,666	-25%	-$69.3K	﹤0.01%	1109
2022 Q1	$474K	Buy	26,353 +13,333	+102%	+$235K	0.01%	950
2021 Q4	$342K	Buy	13,020 +10,587	+435%	+$324K	0.01%	1070
2021 Q3	$87K	Sell	2,433 -6,127	-72%	-$260K	﹤0.01%	1258
2021 Q2	$470K	Sell	8,560 -3,132	-27%	-$207K	0.01%	1083
2021 Q1	$970K	Hold	11,692	–	–	0.02%	874
2020 Q4	$1.33M	Sell	11,692 -3,066	-21%	-$194K	0.03%	675
2020 Q3	$449K	Buy	14,758 +5,333	+57%	+$204K	0.01%	939
2020 Q2	$414K	Buy	9,425 +5,560	+144%	+$231K	0.01%	921
2020 Q1	$139K	Buy	3,865 +798	+26%	+$39.5K	﹤0.01%	1136
2019 Q4	$205K	Hold	3,067	–	–	﹤0.01%	1194
2019 Q3	$476K	Buy	+3,067	New	+$347K	0.01%	976

Other funds holding SLDB